A whole methylome CpG-SNP association study of psychosis in blood and brain tissue

Schizophrenia Bulletin

Volumn 42, Issue 4, 2016, Pages 1018-1026

  Van Den Oord, Edwin J C G ^a   Clark, Shaunna L ^a   Xie, Lin Ying ^a   Shabalin, Andrey A ^a   Dozmorov, Mikhail G ^a   Kumar, Gaurav ^a   Vladimirov, Vladimir I ^a,b,c   Magnusson, Patrik K E ^d   Aberg, Karolina A ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^b VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

^c JOHNS HOPKINS UNIVERSITY   (United States)

^d KAROLINSKA INSTITUTE   (Sweden)

Author keywords

DNA methylation; MBD seq; Methylome wide association study; Postmortem brain samples; Psychosis; SNPs

Indexed keywords

BIOLOGICAL MARKER; BISULFITE; METHYL CPG BINDING PROTEIN; ACTIN BINDING PROTEIN; ECTODERMAL-NEURAL CORTEX 1 PROTEIN; NEUROPEPTIDE; NUCLEAR PROTEIN;

ADULT; ARTICLE; BLOOD; BLOOD SAMPLING; BRAIN TISSUE; CONTROLLED STUDY; CPG ISLAND; DNA METHYLATION; FEMALE; GENE REPLICATION; GENETIC ASSOCIATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PSYCHOSIS; PYROSEQUENCING; SCHIZOPHRENIA; SINGLE NUCLEOTIDE POLYMORPHISM; AGED; AUTOPSY; BRAIN; CASE CONTROL STUDY; GENETICS; GENOME-WIDE ASSOCIATION STUDY; METABOLISM; MIDDLE AGED;

ADULT; AGED; AUTOPSY; BIOMARKERS; BRAIN; CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; FEMALE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MALE; MICROFILAMENT PROTEINS; MIDDLE AGED; NEUROPEPTIDES; NUCLEAR PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE; PSYCHOTIC DISORDERS; SCHIZOPHRENIA;

EID: 84979248318     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbv182     Document Type: Article

References (69)

1. Ehrlich M, Wang RY. 5-Methylcytosine in eukaryotic DNA. Science. 1981;212:1350-1357.
2. Bird A. The dinucleotide CG as a genomic signalling module. J Mol Biol. 2011;409:47-53.
3. Shoemaker R, Deng J, Wang W, Zhang K. Allele-specific methylation is prevalent and is contributed by CpG-SNPs in the human genome. Genome Res. 2010;20:883-889.
4. Dayeh TA, Olsson AH, Volkov P, Almgren P, Rönn T, Ling C. Identification of CpG-SNPs associated with type 2 diabetes and differential DNA methylation in human pancreatic islets. Diabetologia. 2013;56:1036-1046.
5. Taqi MM, Bazov I, Watanabe H, et al. Prodynorphin CpG-SNPs associated with alcohol dependence: elevated methylation in the brain of human alcoholics. Addict Biol. 2011;16:499-509.
6. Chan SW, Henderson IR, Jacobsen SE. Gardening the genome: DNA methylation in Arabidopsis thaliana. Nat Rev Genet. 2005;6:351-360.
7. Kapoor A, Agius F, Zhu JK. Preventing transcriptional gene silencing by active DNA demethylation. FEBS Lett. 2005;579:5889-5898.
8. Hsieh J, Fire A. Recognition and silencing of repeated DNA. Annu Rev Genet. 2000;34:187-204.
9. Hsieh CL. Dependence of transcriptional repression on CpG methylation density. Mol Cell Biol. 1994;14:5487-5494.
10. Prendergast GC, Ziff EB. Methylation-sensitive sequencespecific DNA binding by the c-Myc basic region. Science. 1991;251:186-189.
11. Shukla S, Kavak E, Gregory M, et al. CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing. Nature. 2011;479:74-79.
12. Maunakea AK, Nagarajan RP, Bilenky M, et al. Conserved role of intragenic DNA methylation in regulating alternative promoters. Nature. 2010;466:253-257.
13. Deaton AM, Webb S, Kerr AR, et al. Cell type-specific DNA methylation at intragenic CpG islands in the immune system. Genome Res. 2011;21:1074-1086.
14. Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev. 2011;25:1010-1022.
15. Mohn F, Weber M, Schübeler D, Roloff TC. Methylated DNA immunoprecipitation (MeDiP). Methods Mol Biol. 2009;507:55-64.
16. Serre D, Lee BH, Ting AH. MBD-isolated Genome Sequencing provides a high-throughput and comprehensive survey of DNA methylation in the human genome. Nucleic Acids Res. 2010;38:391-399.
17. Li N, Ye M, Li Y, et al. Whole genome DNA methylation analysis based on high throughput sequencing technology. Methods. 2010;52:203-212.
18. Harris RA, Wang T, Coarfa C, et al. Comparison of sequencing-based methods to profile DNA methylation and identification of monoallelic epigenetic modifications. Nat Biotechnol. 2010;28:1097-1105.
19. Hogart A, Lichtenberg J, Ajay SS, Anderson SM, Margulies EH, Bodine DM. Genome-wide DNA methylation profiles in hematopoietic stem and progenitor cells reveal over-representation of ETS transcription factor binding sites. Genome Res. 2012;22:1407-1418.
20. Lan X, Adams C, Landers M, et al. High resolution detection and analysis of CpG dinucleotides methylation using MBDSeq technology. PLoS One. 2011;6:e22226.
21. Nair SS, Coolen MW, Stirzaker C, et al. Comparison of methyl-DNA immunoprecipitation (MeDiP) and methyl-CpG binding domain (MBD) protein capture for genomewide DNA methylation analysis reveal CpG sequence coverage bias. Epigenetics. 2011;6:34-44.
22. McClay JL, Aberg KA, Clark SL, et al. A methylome-wide study of aging using massively parallel sequencing of the methyl-CpG-enriched genomic fraction from blood in over 700 subjects. Hum Mol Genet. 2014;23:1175-1185.
23. Aberg KA, McClay JL, Nerella S, et al. Methylome-wide association study of schizophrenia: identifying blood biomarker signatures of environmental insults. JAMA Psychiatry. 2014;71:255-264.
24. Feinberg AP. Phenotypic plasticity and the epigenetics of human disease. Nature. 2007;447:433-440.
25. Davies MN, Volta M, Pidsley R, et al. Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood. Genome Biol. 2012;13:R43.
26. Christensen BC, Houseman EA, Marsit CJ, et al. Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet. 2009;5:e1000602.
27. Eckhardt F, Lewin J, Cortese R, et al. DNA methylation profiling of human chromosomes 6, 20 and 22. Nat Genet. 2006;38:1378-1385.
28. Ripke S, O'Dushlaine C, Chambert K, et al. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat Genet. 2013;45:1150-1159.
29. Bergen SE, O'Dushlaine CT, Ripke S, et al. Genome-wide association study in a Swedish population yields support for greater CNV and MHC involvement in schizophrenia compared with bipolar disorder. Mol Psychiatry. 2012;17:880-886.
30. Kristjansson E, Allebeck P, Wistedt B. Validity of the diagnosis of schizophrenia in a psychiatric inpatient register. Nordisk Psykiatrik Tidsskrift. 1987;41:229-234.
31. Dalman C, Broms J, Cullberg J, Allebeck P. Young cases of schizophrenia identified in a national inpatient register-are the diagnoses valid? Soc Psychiatry Psychiatr Epidemiol. 2002;37:527-531.
32. Ekholm B, Ekholm A, Adolfsson R, et al. Evaluation of diagnostic procedures in Swedish patients with schizophrenia and related psychoses. Nord J Psychiatry. 2005;59:457-464.
33. Price AL, Patterson NJ, Plenge RM, Weinblatt ME, Shadick NA, Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat Genet. 2006;38:904-909.
34. Howie B, Fuchsberger C, Stephens M, Marchini J, Abecasis GR. Fast and accurate genotype imputation in genome-wide association studies through pre-phasing. Nat Genet. 2012;44:955-959.
35. Aberg KA, McClay JL, Nerella S, et al. MBD-seq as a costeffective approach for methylome-wide association studies: demonstration in 1500 case-control samples. Epigenomics. 2012;4:605-621.
36. Bock C, Tomazou EM, Brinkman AB, et al. Quantitative comparison of genome-wide DNA methylation mapping technologies. Nat Biotechnol. 2010;28:1106-1114.
37. Aberg KA, Xie L, Chan RF, et al. Evaluation of methyl-binding domain based enrichment approaches revisited. PLoS One. 2015;10:e0132205.
38. van den Oord EJ, Bukszar J, Rudolf G, et al. Estimation of CpG coverage in whole methylome next-generation sequencing studies. BMC Bioinformatics. 2013;14:50.
39. Chen W, Gao G, Nerella S, et al. methylPCA: a toolkit for principal component analysis in methylome-wide association studies [published online ahead of print March 2, 2013]. BMC Bioinformatics.
40. Houseman EA, Accomando WP, Koestler DC, et al. DNA methylation arrays as surrogate measures of cell mixture distribution. BMC Bioinformatics. 2012;13:86.
41. Liu Y, Aryee MJ, Padyukov L, et al. Epigenome-wide association data implicate DNA methylation as an intermediary of genetic risk in rheumatoid arthritis. Nat Biotechnol. 2013;31:142-147.
42. Sun YV, Turner ST, Smith JA, et al. Comparison of the DNA methylation profiles of human peripheral blood cells and transformed B-lymphocytes. Hum Genet. 2010;127:651-658.
43. Torrey EF, Webster M, Knable M, Johnston N, Yolken RH. The stanley foundation brain collection and neuropathology consortium. Schizophr Res. 2000;44:151-155.
44. Deep-Soboslay A, Iglesias B, Hyde TM, et al. Evaluation of tissue collection for postmortem studies of bipolar disorder. Bipolar Disord. 2008;10:822-828.
45. Smoller JW, Craddock N, Kendler K, et al. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet. 2013;381:1371-1379.
46. Liu C, Cheng L, Badner JA, et al. Whole-genome association mapping of gene expression in the human prefrontal cortex. Mol Psychiatry. 2010;15:779-784.
47. Tost J, Dunker J, Gut IG. Analysis and quantification of multiple methylation variable positions in CpG islands by Pyrosequencing. Biotechniques. 2003;35:152-156.
48. Aparicio A, North B, Barske L, et al. LINE-1 methylation in plasma DNA as a biomarker of activity of DNA methylation inhibitors in patients with solid tumors. Epigenetics. 2009;4:176-184.
49. van den Oord EJ, Sullivan PF. False discoveries and models for gene discovery. Trends Genet. 2003;19:537-542.
50. Dozmorov MG, Cara LR, Giles CB, Wren JD. GenomeRunner: automating genome exploration. Bioinformatics. 2012;28:419-420.
51. Wang D, Zhang S, Li L, Liu X, Mei K, Wang X. Structural insights into the assembly and activation of IL-1beta with its receptors. Nat Immunol. 2010;11:905-911.
52. Fineberg AM, Ellman LM. Inflammatory cytokines and neurological and neurocognitive alterations in the course of schizophrenia. Biol Psychiatry. 2013;73:951-966.
53. Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review. Biol Psychiatry. 2008;63:801-808.
54. Katila H, Appelberg B, Hurme M, Rimón R. Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders. Schizophr Res. 1994;12:29-34.
55. Akiyama K. Serum levels of soluble IL-2 receptor alpha, IL-6 and IL-1 receptor antagonist in schizophrenia before and during neuroleptic administration. Schizophr Res. 1999;37:97-106.
56. Ellman LM, Deicken RF, Vinogradov S, et al. Structural brain alterations in schizophrenia following fetal exposure to the inflammatory cytokine interleukin-8. Schizophr Res. 2010;121:46-54.
57. Nawa H, Takahashi M, Patterson PH. Cytokine and growth factor involvement in schizophrenia-support for the developmental model. Mol Psychiatry. 2000;5:594-603.
58. Müller N, Ackenheil M. Psychoneuroimmunology and the cytokine action in the CNS: implications for psychiatric disorders. Prog Neuropsychopharmacol Biol Psychiatry. 1998;22:1-33.
59. Tohmi M, Tsuda N, Watanabe Y, Kakita A, Nawa H. Perinatal inflammatory cytokine challenge results in distinct neurobehavioral alterations in rats: implication in psychiatric disorders of developmental origin. Neurosci Res. 2004;50:67-75.
60. Smith DE, Lipsky BP, Russell C, et al. A central nervous system-restricted isoform of the interleukin-1 receptor accessory protein modulates neuronal responses to interleukin-1. Immunity. 2009;30:817-831.
61. Mistry M, Gillis J, Pavlidis P. Genome-wide expression profiling of schizophrenia using a large combined cohort. Mol Psychiatry. 2013;18:215-225.
62. Schizophrenia Working Group of the Psychiatric Genomics Consortium. Biological insights from 108 schizophreniaassociated genetic loci. Nature. 2014;511:421-427.
63. Maeder ML, Angstman JF, Richardson ME, et al. Targeted DNA demethylation and activation of endogenous genes using programmable TALE-TET1 fusion proteins. Nat Biotechnol. 2013;31:1137-1142.
64. Voigt P, Reinberg D. Epigenome editing. Nat Biotechnol. 2013;31:1097-1099.
65. Chen H, Kazemier HG, de Groote ML, Ruiters MH, Xu GL, Rots MG. Induced DNA demethylation by targeting Ten-Eleven Translocation 2 to the human ICAM-1 promoter. Nucleic Acids Res. 2014;42:1563-1574.
66. Sahin E, Haubenwallner S, Kuttke M, et al. Macrophage PTEN regulates expression and secretion of arginase I modulating innate and adaptive immune responses. J Immunol. 2014;193:1717-1727.
67. Robert I, Sutter A, Quirin-Stricker C. Synergistic activation of the human choline acetyltransferase gene by c-Myb and C/EBPbeta. Brain Res Mol Brain Res. 2002;106:124-135.
68. Emiliani FE, Sedlak TW, Sawa A. Oxidative stress and schizophrenia: recent breakthroughs from an old story. Curr Opin Psychiatry. 2014;27:185-190.
69. Karkkainen V, Pomeshchik Y, Savchenko E, et al. Nrf2 regulates neurogenesis and protects neural progenitor cells against Abeta toxicity. Stem Cells. 2014;32:1904-1916.